Filings with the SEC since Sep 15, 2022
254 filings, 5 in the last 30 days
Annual report (10-K)Quarterly report (10-Q)Current report (8-K)Auditor changeCEO, CFO, COO or CAO changeRestatementLate filing noticeInsider purchaseCluster buy (3+ insiders)SEC comment letterShare offering (S-3, 424B)
All 86 events
- Oct 6, 20268-K Material agreement signed, Other events 8-K items 1.01, 8.01
- Aug 21, 2026Buy Bailey David F (Chief Executive Officer) bought $210K open-market purchase on Aug 19, 2026
- Aug 20, 2026Buy Bailey David F (Chief Executive Officer) bought $25K open-market purchase on Aug 18, 2026
- Aug 14, 20268-K Quarterly results 8-K item 2.02
- Aug 13, 202610-Q Quarterly report (10-Q) period ended Jun 30, 2026
- Aug 4, 20268-K Director or officer change 8-K item 5.02
- Jun 22, 2026Auditor Auditor change 8-K item 4.01
- Jun 11, 20268-K New debt or obligation, Regulation FD disclosure, Other events 8-K items 2.03, 7.01, 8.01
- May 28, 2026Buy Bailey David F (Chief Executive Officer) bought $683K open-market purchase on May 26, 2026
- May 28, 2026Buy Bailey David F (Chief Executive Officer) bought $310K open-market purchase on May 28, 2026
- May 22, 20268-K Shareholder rights changed, Director or officer change, Bylaws or fiscal year changed, Regulation FD disclosure 8-K items 3.03, 5.02, 5.03, 7.01
- May 13, 20268-K Quarterly results 8-K item 2.02
- May 13, 202610-Q Quarterly report (10-Q) period ended Mar 31, 2026
- May 12, 20268-K Shareholder vote results 8-K item 5.07
- May 7, 20268-K Material agreement signed, Director or officer change 8-K items 1.01, 5.02
- Apr 24, 2026Offering At-the-market program: up to $5.0B of common stock 424B3 · In accordance with the terms of the Sales Agreement, from time to time we may offer and sell shares of our Common Stock having an aggregate gross sales price of up to $5,000,000,000 to or through the Agents, acting as principal and/or the designated sales agent, pursuant to this prospectus.
- Apr 17, 2026Offering Shelf registration: shares and other securities, amount not fixed S-3/A · may offer and sell from time to time shares of our Common Stock, shares of our preferred stock, debt securities, warrants, rights, purchase contracts or units, or any combination thereof, having an initial offering price not to exceed $6,993,570,615.16, which may be issued in one or more series and
- Apr 9, 2026Offering Shelf registration: shares and other securities, amount not fixed S-3 · may offer and sell from time to time shares of our Common Stock, shares of our preferred stock, debt securities, warrants, rights, purchase contracts or units, or any combination thereof, having an initial offering price not to exceed $6,993,570,615.16, which may be issued in one or more series and
- Apr 7, 20268-K Current report (amended) 8-K
- Mar 31, 2026Offering Sale of 2.1M new shares 424B3 · Shares sold
- Mar 31, 20268-K Quarterly results 8-K item 2.02
- Mar 30, 202610-K Annual report (10-K) period ended Dec 31, 2025
- Feb 26, 2026Offering Sale of 2.1M new shares 424B3 · Shares sold
- Feb 26, 20268-K Material agreement signed, Acquisition or sale of assets completed, Unregistered share sale, Director or officer change, Regulation FD disclosure 8-K items 1.01, 2.01, 3.02, 5.02, 7.01
- Feb 19, 20268-K Regulation FD disclosure 8-K item 7.01
- Feb 17, 2026Offering Sale of 2.1M new shares 424B3 · Shares sold
- Feb 17, 20268-K Material agreement signed, Unregistered share sale, Regulation FD disclosure 8-K items 1.01, 3.02, 7.01
- Feb 2, 2026Offering Sale of 2.1M new shares 424B3 · Shares sold
- Feb 2, 20268-K Material agreement signed 8-K item 1.01
- Jan 23, 2026Offering Sale of 2.1M new shares 424B3 · Shares sold
- Jan 21, 20268-K Bylaws or fiscal year changed, Regulation FD disclosure 8-K items 5.03, 7.01
- Dec 18, 20258-K Shareholder vote results, Regulation FD disclosure, Other events 8-K items 5.07, 7.01, 8.01
- Dec 12, 20258-K Listing notice 8-K item 3.01
- Dec 9, 20258-K Material agreement signed, New debt or obligation 8-K items 1.01, 2.03
- Dec 8, 2025Officer CFO and CAO change On December 8, 2025, the Board of Directors (the “Board”) of Kindly MD, Inc., a Utah corporation (the “Company”) appointed Teresa Gendron, age 56, as Chief Financial Officer of the Company, effective December 8, 2025 (the “Effective Date”).
- Nov 21, 2025Offering Sale of 2.1M new shares 424B3 · Shares sold
- Nov 19, 20258-K Quarterly results 8-K item 2.02
- Nov 19, 202510-Q Quarterly report (10-Q) period ended Sep 30, 2025
- Nov 14, 2025Late filing Late filing notice: the 10-Q will be late NT 10-Q (Form 12b-25), period ended Sep 30, 2025
- Oct 7, 2025Offering Sale of 2.1M new shares 424B3 · Shares sold
- Oct 7, 20258-K Material agreement signed, New debt or obligation, Regulation FD disclosure 8-K items 1.01, 2.03, 7.01
- Oct 6, 2025Offering Sale of 2.1M new shares 424B3 · Shares sold
- Oct 3, 20258-K Material agreement signed, Material agreement ended, New debt or obligation, Director or officer change, Regulation FD disclosure 8-K items 1.01, 1.02, 2.03, 5.02, 7.01
- Sep 29, 2025Offering Sale of 2.1M new shares 424B3 · Shares sold
- Sep 29, 2025Offering Sale of 2.1M new shares 424B3 · Shares sold
- Sep 29, 2025Offering Sale of 2.1M new shares 424B3 · Shares sold
- Sep 26, 20258-K Director nominations, Other events 8-K items 5.08, 8.01
- Sep 16, 20258-K Regulation FD disclosure 8-K item 7.01
- Sep 16, 20258-K Other events 8-K item 8.01
- Sep 10, 20258-K Material agreement signed, Regulation FD disclosure, Other events 8-K items 1.01, 7.01, 8.01
- Sep 5, 2025Offering Sale of 2.1M new shares 424B3 · Shares sold
- Sep 5, 20258-K Material agreement signed, Regulation FD disclosure 8-K items 1.01, 7.01
- Sep 4, 2025Offering Sale of 2.1M new shares 424B3 · Shares sold
- Sep 4, 2025Offering Sale of 2.1M new shares 424B3 · Shares sold
- Aug 28, 20258-K Other events 8-K item 8.01
- Aug 26, 2025Offering Shelf registration: shares and other securities, amount not fixed S-3ASR · Contracts Units Kindly MD, Inc. (the “Company” or “we”) may offer and sell from time to time shares of our common stock, shares of our preferred stock, debt securities, warrants, rights, purchase contracts or units, or any combination thereof, which may be issued in one or more series and which may
- Aug 26, 20258-K Other events (amended) 8-K item 8.01
- Aug 18, 2025Offering Sale of 2.1M new shares 424B3 · Shares sold
- Aug 15, 20258-K Material agreement signed, Acquisition or sale of assets completed, New debt or obligation, Listing notice, Unregistered share sale, Shareholder rights changed, Change in control, Director or officer change, Bylaws or fiscal year changed, Code of ethics changed, Regulation FD disclosure, Other events 8-K items 1.01, 2.01, 2.03, 3.01, 3.02, 3.03, 5.01, 5.02, 5.03, 5.05, 7.01, 8.01
- Aug 6, 2025Offering Sale of 2.1M new shares 424B3 · Shares sold
- Aug 5, 202510-Q Quarterly report (10-Q) period ended Jun 30, 2025
- Jul 24, 2025Offering Sale of 2.1M new shares 424B3 · Shares sold
- Jul 21, 2025SEC letter SEC asked 6 questions about Schedule 14C letters 2025-07-09 to 2025-07-21 · Crypto assets, Acquisitions, Debt
- Jun 25, 20258-K Regulation FD disclosure 8-K item 7.01
- Jun 20, 2025Offering Sale of 2.1M new shares 424B3 · Shares sold
- Jun 20, 20258-K Material agreement signed, Unregistered share sale, Shareholder vote results, Regulation FD disclosure 8-K items 1.01, 3.02, 5.07, 7.01
- Jun 18, 20258-K Regulation FD disclosure 8-K item 7.01
- Jun 17, 20258-K Regulation FD disclosure 8-K item 7.01
- May 28, 2025Offering Sale of 2.1M new shares 424B3 · Shares sold
- May 27, 20258-K Other events 8-K item 8.01
- May 23, 2025Offering Sale of 2.1M new shares 424B3 · Shares sold
- May 23, 20258-K Other events 8-K item 8.01
- May 21, 2025Offering Sale of 2.1M new shares 424B3 · Shares sold
- May 21, 20258-K Regulation FD disclosure 8-K item 7.01
- May 20, 20258-K Shareholder vote results, Regulation FD disclosure 8-K items 5.07, 7.01
- May 19, 2025Offering Sale of 2.1M new shares 424B3 · Shares sold
- May 16, 20258-K Director or officer change, Other events 8-K items 5.02, 8.01
- May 12, 2025Offering Sale of 2.1M new shares 424B3 · Shares sold
- May 12, 20258-K Material agreement signed, New debt or obligation, Unregistered share sale, Regulation FD disclosure 8-K items 1.01, 2.03, 3.02, 7.01
- May 9, 2025Offering Sale of 2.1M new shares 424B3 · Shares sold
- May 8, 202510-Q Quarterly report (10-Q) period ended Mar 31, 2025
- May 7, 2025Offering Sale of 2.1M new shares 424B4 · Shares sold
- Apr 17, 202510-K Annual report (10-K) (amended) period ended Dec 31, 2024
- Mar 28, 202510-K Annual report (10-K) period ended Dec 31, 2024
- Nov 13, 20248-K Shareholder vote results 8-K item 5.07
- Nov 12, 202410-Q Quarterly report (10-Q) period ended Sep 30, 2024
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind
All 254
Annual & quarterly 11Current reports (8-K) 47Insiders 72Proxy & votes 12Big owners (13D/13G) 7Shares & debt offered 36SEC letters 25Other 44
| Filed | Form | What it is | Period | |
|---|---|---|---|---|
| Oct 29, 2026 | DEFA14A | Extra proxy material | all files | |
| Oct 29, 2026 | DEF 14A | Proxy statement | Oct 29, 2026 | all files |
| Oct 14, 2026 | PRE 14A | Oct 14, 2026 | all files | |
| Apr 17, 2026 | DEF 14A | Proxy statement | Apr 17, 2026 | all files |
| Apr 7, 2026 | PRE 14A | Apr 7, 2026 | all files | |
| Nov 3, 2025 | DEFA14A | Extra proxy material | all files | |
| Nov 3, 2025 | DEFA14A | Extra proxy material | all files | |
| Nov 3, 2025 | DEF 14A | Proxy statement | Dec 17, 2025 | all files |
| Oct 23, 2025 | PRE 14A | Oct 22, 2025 | all files | |
| Jul 22, 2025 | DEF 14C | Jul 22, 2025 | all files | |
| Sep 19, 2024 | DEF 14A | Proxy statement | Sep 19, 2024 | all files |
| Sep 6, 2024 | PRE 14A | Sep 6, 2024 | all files |
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.